Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders
1 other identifier
interventional
59
1 country
1
Brief Summary
This study aims to examine different ways of motivating people to make use of Maya, a mobile cognitive behavior therapy (CBT) program for adolescents and young adults experiencing anxiety symptoms, and to assess whether social supports are as efficacious, or more efficacious, than other non-monetary incentives. Subjects will use the Maya app for at least 20 minutes per day, 2 days per week, for 6 weeks. Assessments will include a weekly check in with a member of the research team, questionnaires, and an optional magnetic resonance imaging (MRI) recording.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2021
CompletedFirst Submitted
Initial submission to the registry
November 11, 2021
CompletedFirst Posted
Study publicly available on registry
November 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2022
CompletedResults Posted
Study results publicly available
October 15, 2024
CompletedOctober 15, 2024
October 1, 2024
1.4 years
November 11, 2021
January 16, 2024
October 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Anxious Symptoms From Baseline to End of Treatment (Week 6)
Change in anxiety between the three incentive conditions will be measured using the Hamilton Rating Scale for Anxiety (HAM-A), a 14-item questionnaire measure of the severity of anxiety symptoms. The items measure both psychic anxiety and somatic anxiety, where higher scores, defined by a score range of 18-56, indicate a greater presence of symptoms and lower scores, defined by a score range of 0-17, indicate mild to no anxiety symptoms.
Baseline to week 6 (end of intervention)
Change in Anxious Symptoms From Baseline to End of Treatment (Week 6)
Change in anxiety between the three incentive conditions will be measured using the Anxiety Sensitivity Index (ASI). The ASI is an 18-item scale containing three subscales measuring physical, cognitive, and social concerns regarding anxiety. Higher scores, defined by a score range of 18-72, reflect greater self-reported concern and lower scores, defined by a score range of 0-17, reflect little self-reported concern.
Baseline to week 6 (end of intervention)
Change in Anxious Symptoms From Baseline to End of Treatment (Week 6)
Change in anxiety between the three incentive conditions will be measured using the the Leibowitz Social Anxiety Scale (LSAS). The LSAS is a 24-item scale measuring fear and avoidance across social situations with a total score range of 0-144. Higher scores, defined by a total score range of 50-95 or greater, indicate greater fear and avoidance severity and lower scores, defined by a total score range of 0-49, indicate mild to no fear or avoidance.
Baseline to week 6 (end of intervention)
Secondary Outcomes (2)
Mean Number of Sessions Completed
End of intervention (week 6)
Mean Rating Score on the Mobile Application Rating Scale
End of intervention (week 6)
Study Arms (3)
Social Support
EXPERIMENTALParticipants receive treatment with the Maya app in conjunction with social support incentives for 6 weeks.
Gain Framed
EXPERIMENTALParticipants receive treatment with the Maya app in conjunction with gain-framed incentives for 6 weeks.
Loss Framed
EXPERIMENTALParticipants receive treatment with the Maya app in conjunction with loss-framed incentives for 6 weeks.
Interventions
The Maya app teaches cognitive behavioral therapy (CBT) techniques including emotion monitoring, cognitive restructuring, mindfulness, and exposure to help individuals with anxiety.
Participants earn points and badges for completing sessions, homework, and skills on time and receive post session feedback via text message. Participants can identify a person they know to receive updates about their progress and support them throughout their time in the program. Participants will not be required to choose a person they know to receive updates about their use of the program; instead, they can choose to have a member of the study team serve as their social support if they are assigned to this condition.
Participants earn points and badges for completing sessions, homework, and skills on time and receive post session feedback via text message.
Participants lost points and badges for not completing sessions, homework, and skills on time and receive post session feedback via text message.
Eligibility Criteria
You may qualify if:
- Between the ages of 18 and 25
- Primary diagnosis of an anxiety disorder, as determined by a score of 4 on the Clinical Severity Rating from the Anxiety Disorders Interview Schedule (ADIS)
You may not qualify if:
- Score of \< 4 on the ADIS
- Primary psychiatric diagnosis other than an anxiety disorder
- Currently in cognitive behavioral therapy outside of the study
- Change in dose of a psychiatric medication in the past 12 weeks
- Intent or plan to attempt suicide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medical College
New York, New York, 10065, United States
Related Publications (1)
Bress JN, Falk A, Schier MM, Jaywant A, Moroney E, Dargis M, Bennett SM, Scult MA, Volpp KG, Asch DA, Balachandran M, Perlis RH, Lee FS, Gunning FM. Efficacy of a Mobile App-Based Intervention for Young Adults With Anxiety Disorders: A Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 1;7(8):e2428372. doi: 10.1001/jamanetworkopen.2024.28372.
PMID: 39163044DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Maddy Schier
- Organization
- Weill Cornell Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Faith Gunning, PhD
Weill Medical College of Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2021
First Posted
November 23, 2021
Study Start
June 18, 2021
Primary Completion
November 3, 2022
Study Completion
December 8, 2022
Last Updated
October 15, 2024
Results First Posted
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share